tiprankstipranks
Trending News
More News >
CG Oncology, Inc. (CGON)
NASDAQ:CGON
US Market

CG Oncology, Inc. (CGON) Stock News & Sentiment

Compare
159 Followers
Premium
Company Announcements
CG Oncology Advances Bladder Cancer Therapies in Q1 2025
8d ago
Premium
Ratings
Promising Outlook for CG Oncology: Strong Financial Health and Positive Trial Results for Cretostimogene
8d ago
Premium
Ratings
CG Oncology, Inc.: Promising Outlook with Strong Clinical Performance and Strategic BLA Submission
8d ago
Premium
Ratings
Promising Prospects for CG Oncology’s Cretostimogene in NMIBC Treatment: Superior Efficacy and Strategic Expansion
8d ago
Premium
Ratings
Buy Rating for CG Oncology, Inc. Driven by Cretostimogene’s Potential in Bladder Cancer Treatment Amid BCG Shortage
22d ago
CG Oncology Stock (CGON) Surges 25% As Cancer Drug Shows Remarkable Results
Premium
Market News
CG Oncology Stock (CGON) Surges 25% As Cancer Drug Shows Remarkable Results
23d ago
Premium
Company Announcements
CG Oncology Announces Promising Phase 3 Trial Results
23d ago
More CGON News >

News Score - Last 7 Days

Neutral
CGON
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average61%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CGON’s Media Buzz Sentiment?
Currently, no data Available
What is CGON’s weekly average amount of articles?
Currently, no data Available
What is CGON’s News Sentiment?
59% of articles about CGON were positive this week, compared to its sector average of 61%.
    General Stocks that are Trending in the News
    XLM-USDStellar
    CPACopa Holdings
    ATOM-USDCosmos
    CRO-USDCronos
    Showing the stocks with the most bullish news sentiment over the past week
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis